Difference between revisions of "Nodular hyperplasia of the prostate gland"

Jump to navigation Jump to search
Line 65: Line 65:
Notes:
Notes:
*Should '''not''' be diagnosed on core biopsy!
*Should '''not''' be diagnosed on core biopsy!
*Cancer rates varies substaintially in resections done for BPH.
*One series suggests clinically relevant prostate cancer is seen in ~1.5% of resections for BPH.<ref>{{Cite journal  | last1 = Skrzypczyk | first1 = MA. | last2 = Dobruch | first2 = J. | last3 = Nyk | first3 = L. | last4 = Szostek | first4 = P. | last5 = Szempliński | first5 = S. | last6 = Borówka | first6 = A. | title = Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessed by a pathologist? | journal = Cent European J Urol | volume = 67 | issue = 3 | pages = 227-32 | month =  | year = 2014 | doi = 10.5173/ceju.2014.03.art2 | PMID = 25247076 }}</ref>
**One series suggests clinically relevant prostate cancer is seen in ~1.5% of cases.<ref>{{Cite journal  | last1 = Skrzypczyk | first1 = MA. | last2 = Dobruch | first2 = J. | last3 = Nyk | first3 = L. | last4 = Szostek | first4 = P. | last5 = Szempliński | first5 = S. | last6 = Borówka | first6 = A. | title = Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessed by a pathologist? | journal = Cent European J Urol | volume = 67 | issue = 3 | pages = 227-32 | month =  | year = 2014 | doi = 10.5173/ceju.2014.03.art2 | PMID = 25247076 }}</ref>


DDx:
DDx:
48,475

edits

Navigation menu